Responses
Regular and Young Investigator Award Abstracts
Immunotherapy Toxicities
1229 Pre-treatment plasma proteomics-based predictive biomarkers for immune related adverse events in non-small cell lung cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
